pancopride has been researched along with Vomiting in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez Campos, A | 1 |
| Díaz-Rubio, E; Fernández, A; Guillem, V; Martin, M; Moreno, I; Pérez, A; Rosell, R; Soriano, V | 1 |
| Beleta, J; Berga, P; Bou, J; Doménech, T; Fernández, AG; Gristwood, RW; Puig, J; Roberts, DJ | 1 |
1 review(s) available for pancopride and Vomiting
| Article | Year |
|---|---|
[The clinical development of an antiemetic in oncology. A meta-analysis].
Topics: Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Humans; Neoplasms; Serotonin Antagonists; Vomiting | 1994 |
2 other study(ies) available for pancopride and Vomiting
| Article | Year |
|---|---|
LAS 30451: a novel 5-HT3 antagonist.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Humans; Male; Receptors, Serotonin; Serotonin Antagonists; Vomiting | 1993 |
Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
Topics: Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Dogs; Guinea Pigs; Male; Metoclopramide; Rabbits; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Swine; Vomiting | 1992 |